Welcome to Paratek Medical Affairs
This web portal is intended as an educational resource for healthcare professionals practicing in the U.S. Information provided is for informational purposes and is not intended to promote the use of any product. Please review the relevant package insert for safety information and directions for use before prescribing medications.
Are you a health professional practicing in the United States?

Welcome to Paratek
Medical Affairs

Welcome to Paratek
Medical Affairs

Welcome to Paratek
Medical Affairs

Disease Education Resources

Educational tools and resources related to antimicrobial resistance (AMR) can be accessed on www.InfectionsandAMR.com.

Additional resources on community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) will be available soon.

Antimicrobial Resistance (AMR)

AMR within a wide range of infectious agents is a growing problem and threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi. AMR develops when microorganisms such as bacteria evolve to withstand the effects of the antimicrobial therapeutics that would have previously killed them or prevented their growth.

AMR is a serious global issue and requires urgent action. More than 2.8 million antibiotic-resistant infections occur annually in the United States alone, and more than 35,000 people die as a result.

Community-Acquired Bacterial Pneumonia (CABP)

CABP is an acute bacterial infection of the pulmonary parenchyma associated with chest pain, cough, sputum production, difficulty breathing, chills, rigors, fever, or hypotension, and is accompanied by the presence of a new lobar or multilobar infiltrate on a chest radiograph.

Streptococcus pneumoniae is a major cause of bacterial pneumonia and has developed resistance to clinically relevant antibiotics including macrolides, penicillins, and older generation tetracyclines.

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

ABSSSIs include cellulitis, erysipelas, wound infection, and major cutaneous abscess with a minimum lesion surface area of approximately 75cm². Common bacterial pathogens causing ABSSSI are Staphylococcus aureus including methicillin-resistant S. aureus (MRSA) and Streptococcus pyogenes.

Although several treatments are available, MRSA has developed resistance to many first-line antibiotics such as beta-lactams, macrolides, and fluoroquinolones.

Contact Us

In light of the COVID-19 pandemic, you may experience a busy signal when calling our Paratek Call Center. Please continue to try your call throughout the day to report adverse events and product quality complaints or obtain medical information for our products.

MSD Contact Form
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

By completing this form, I verify that I requested this information completely independently and solely for my own evaluation and application to my practice, patients, or general education, or for the pharmacy and therapeutics committee. I affirm that my request was in no way prompted by Paratek Pharmaceuticals or any representative of Paratek.

Medical Information
If you would like to speak to a Paratek Medical Information Professional please call Paratek Customer Service at 1-833-PARATEK (1-833-727-2835) (Monday to Friday, 8 AM to 8 PM ET, excluding holidays) or email medinfo@paratekpharma.com
Report a Product Complaint
To report a Product Quality Complaint for a Paratek product, please call 1-833-Paratek (1-833-727-2835).
Report an Adverse Event
To report an Adverse Event for a Paratek product, please fill out a form or call us 1-833-PARATEK (1-833-727-2835). You can also contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Request follow-up from a Medical Science Director
If you would like additional information about our products or would like to discuss research ideas, please contact our MSD team.